AptarGroup, Inc. Stock

Equities

ATR

US0383361039

Non-Paper Containers & Packaging

Real-time Estimate Cboe BZX 03:54:30 2024-06-06 pm EDT 5-day change 1st Jan Change
145.7 USD -1.47% Intraday chart for AptarGroup, Inc. -0.01% +18.20%
Sales 2024 * 3.67B Sales 2025 * 3.85B Capitalization 9.8B
Net income 2024 * 336M Net income 2025 * 374M EV / Sales 2024 * 2.67 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 2.54 x
P/E ratio 2024 *
29.3 x
P/E ratio 2025 *
26.3 x
Employees 13,800
Yield 2024 *
1.19%
Yield 2025 *
1.28%
Free-Float 91.45%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.18%
1 week+2.13%
Current month+0.16%
1 month+0.76%
3 months+3.79%
6 months+17.41%
Current year+19.66%
More quotes
1 week
145.92
Extreme 145.92
148.50
1 month
144.52
Extreme 144.515
151.73
Current year
122.29
Extreme 122.2935
151.73
1 year
111.63
Extreme 111.625
151.73
3 years
90.23
Extreme 90.23
151.73
5 years
79.84
Extreme 79.84
158.97
10 years
55.59
Extreme 55.59
158.97
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 17-01-31
Director of Finance/CFO 61 99-12-31
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 70 10-12-31
Chairman 65 21-05-27
Director/Board Member 68 09-12-31
More insiders
Date Price Change Volume
24-06-06 146.1 -1.22% 81 646
24-06-05 147.9 -0.18% 229,231
24-06-04 148.2 +0.02% 287,867
24-06-03 148.2 +0.32% 264,463
24-05-31 147.7 +1.06% 358,871

Delayed Quote Nyse, June 05, 2024 at 04:00 pm EDT

More quotes
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
147.9 USD
Average target price
159 USD
Spread / Average Target
+7.49%
Consensus